Sexually Transmitted DiseasesAIDS/HIVAIDS/HIV Sexually Transmitted DiseasesFamily PracticeHIV & AIDSNursingPulmonologyInternal MedicineCritical CareEmergency MedicineStdInfectious DiseaseCoronavirus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, July 6, 2020 (HealthDay News) -- Persons with HIV (PWH) hospitalized with COVID-19 have similar outcomes to demographically matched patients without HIV, according to a study published online June 28 in Clinical Infectious Diseases.
Keith Sigel, M.D., Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues compared outcomes for PWH hospitalized with COVID-19 to those of a matched comparison group. Data were included for 88 PWH hospitalized with COVID-19 between March 12 and April 23, 2020, and 405 HIV-uninfected matched comparators (one PWH was matched with up to five patients by age, sex, race/ethnicity, and calendar week of infection).
The researchers found that the proportions of HIV virology control on antiretroviral therapy were high for PWH hospitalized with COVID-19. Greater proportions of smoking and comorbid illness were seen for PWH than demographically similar uninfected comparators. On admission by HIV status, there was no difference noted in COVID-19 severity. Hospitalized PWH frequently had poor outcomes, but the proportions were similar to those of matched comparators; 18 and 21 percent of PWH required mechanical ventilation and died during follow-up compared with 23 and 20 percent of matched comparators, respectively. Over time, the cumulative incidence of death was similar by HIV status.
"If confirmed, investigation of specific factors contributing to similar outcomes in this large group of patients with immune disturbance may provide greater insight into the pathogenesis of severe acute respiratory syndrome coronavirus 2," the authors write.
Two authors disclosed financial ties to the pharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 25, 2022
Read this Next
Other Trending Articles